Peter Brünker
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 19
-
- Microbial Natural Products and Biosynthesis 4
- Co-authors
- Pablo Umaña (12 shared papers)Claudia Ferrara (4 shared papers)Peter Sondermann (5 shared papers)Fiona Stuart (1 shared paper)Jörg Benz (2 shared papers)Arne Christian Rufer (1 shared paper)Inja Waldhauer (2 shared papers)Sandra Grau (1 shared paper)
- Journals
- Blood (4 papers)Gene (3 papers)Cancer Research (3 papers)Molecular Cancer Therapeutics (2 papers)Clinical Cancer Research (2 papers)
- Partner nations
- SwitzerlandGermanyUnited Kingdom
In The Last Decade
Peter Brünker
33 papers receiving 3.4k citations
Peter Brünker's Hit Papers
Peers
Comparison fields: 5 of 86
- Radiology, Nuclear Medicine and Imaging 1.4k
- Oncology 615
- Immunology 482
- Genetics 204
- Pathology and Forensic Medicine 315
Countries citing papers authored by Peter Brünker
This map shows the geographic impact of Peter Brünker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Brünker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Brünker more than expected).
Fields of papers citing papers by Peter Brünker
This network shows the impact of papers produced by Peter Brünker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Brünker. The network helps show where Peter Brünker may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Brünker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell–mediated B-cell cytotoxicity Hit paper breakdown → | 2010 | 798 |
| 2 | Unique carbohydrate–carbohydrate interactions are required for high affinity binding between FcγRIII and antibodies lacking core fucose Hit paper breakdown → | 2011 | 665 |
| 3 | 2005 | 313 | |
| 4 | A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors Hit paper breakdown → | 2016 | 301 |
| 5 | 2006 | 260 | |
| 6 | 2017 | 244 | |
| 7 | 2019 | 226 | |
| 8 | 2016 | 120 | |
| 9 | 2020 | 79 | |
| 10 | 2005 | 76 | |
| 11 | 1998 | 64 | |
| 12 | 2021 | 61 | |
| 13 | 2021 | 53 | |
| 14 | 1998 | 52 | |
| 15 | 1997 | 49 | |
| 16 | 2006 | 45 | |
| 17 | 2020 | 42 | |
| 18 | 1998 | 30 | |
| 19 | 1996 | 26 | |
| 20 | 1999 | 22 |
About Peter Brünker
Peter Brünker is a scholar working on Radiology, Nuclear Medicine and Imaging, Pharmacology, Oncology, Genetics and Biotechnology, having authored 34 papers that have together received 3.6k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (19 papers), Bacterial Genetics and Biotechnology (5 papers), Microbial Natural Products and Biosynthesis (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Glycosylation and Glycoproteins Research (3 papers), Enzyme Production and Characterization (2 papers), Immunotherapy and Immune Responses (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1.4k citations), Oncology (615 citations), Immunology (482 citations), Genetics (204 citations) and Pathology and Forensic Medicine (315 citations). Peter Brünker has collaborated with scholars based in Switzerland, Germany and United Kingdom. Frequent co-authors include Pablo Umaña, Claudia Ferrara, Peter Sondermann, Fiona Stuart, Jörg Benz, Arne Christian Rufer, Inja Waldhauer, Sandra Grau, A. Ruf and M. Stihle. Their work appears in journals such as Blood, Gene, Cancer Research, Molecular Cancer Therapeutics and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.